These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 16022633

  • 21. Mineral density and bone strength are dissociated in long bones of rat osteopetrotic mutations.
    Tuukkanen J, Koivukangas A, Jämsä T, Sundquist K, Mackay CA, Marks SC.
    J Bone Miner Res; 2000 Oct; 15(10):1905-11. PubMed ID: 11028442
    [Abstract] [Full Text] [Related]

  • 22. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC, Borysenko CW, Villa A, Schlesinger PH, Kalla SE, Yaroslavskiy BB, Garćia-Palacios V, Oakley JI, Orchard PJ.
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [Abstract] [Full Text] [Related]

  • 23. Interdependence of skeletal sclerosis and elevated circulating levels of 1,25-dihydroxyvitamin D in osteopetrotic (op and tl) rats.
    Popoff SN, Osier LK, Zerwekh JE, Marks SC.
    Bone; 1994 Aug; 15(5):515-22. PubMed ID: 7980962
    [Abstract] [Full Text] [Related]

  • 24. Lymphocytes and the Dap12 adaptor are key regulators of osteoclast activation associated with gonadal failure.
    Anginot A, Dacquin R, Mazzorana M, Jurdic P.
    PLoS One; 2007 Jul 04; 2(7):e585. PubMed ID: 17611620
    [Abstract] [Full Text] [Related]

  • 25. Osteopetrosis in the rat: coexistence of reductions in osteocalcin and bone resorption.
    Lian JB, Marks SC.
    Endocrinology; 1990 Feb 04; 126(2):955-62. PubMed ID: 2298176
    [Abstract] [Full Text] [Related]

  • 26. [Osteopetrosis, from mouse to man].
    Blin-Wakkach C, Bernard F, Carle GF.
    Med Sci (Paris); 2004 Jan 04; 20(1):61-7. PubMed ID: 14770365
    [Abstract] [Full Text] [Related]

  • 27. Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo.
    Henriksen K, Gram J, Høegh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, Schaller S, Bollerslev J, Karsdal MA.
    Am J Pathol; 2005 Nov 04; 167(5):1341-8. PubMed ID: 16251418
    [Abstract] [Full Text] [Related]

  • 28. Effects of altered bone remodeling and retention of cement lines on bone quality in osteopetrotic aged c-Src-deficient mice.
    Nakayama H, Takakuda K, Matsumoto HN, Miyata A, Baba O, Tabata MJ, Ushiki T, Oda T, McKee MD, Takano Y.
    Calcif Tissue Int; 2010 Feb 04; 86(2):172-83. PubMed ID: 20063091
    [Abstract] [Full Text] [Related]

  • 29. Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice.
    Sakagami N, Amizuka N, Li M, Takeuchi K, Hoshino M, Nakamura M, Nozawa-Inoue K, Udagawa N, Maeda T.
    Micron; 2005 Feb 04; 36(7-8):688-95. PubMed ID: 16182547
    [Abstract] [Full Text] [Related]

  • 30. An adult osteopetrosis model in medaka reveals the importance of osteoclast function for bone remodeling in teleost fish.
    To TT, Witten PE, Huysseune A, Winkler C.
    Comp Biochem Physiol C Toxicol Pharmacol; 2015 Dec 04; 178():68-75. PubMed ID: 26334373
    [Abstract] [Full Text] [Related]

  • 31. Osteopetrosis.
    Tolar J, Teitelbaum SL, Orchard PJ.
    N Engl J Med; 2004 Dec 30; 351(27):2839-49. PubMed ID: 15625335
    [No Abstract] [Full Text] [Related]

  • 32. The synergistic role of Pu.1 and Fms in zebrafish osteoclast-reducing osteopetrosis and possible therapeutic strategies.
    Liu W, Di Q, Li K, Li J, Ma N, Huang Z, Chen J, Zhang S, Zhang W, Zhang Y.
    J Genet Genomics; 2020 Sep 20; 47(9):535-546. PubMed ID: 33184003
    [Abstract] [Full Text] [Related]

  • 33. Human osteopetroses and the osteoclast V-H+-ATPase enzyme system.
    Ogbureke KU, Zhao Q, Li YP.
    Front Biosci; 2005 Sep 01; 10():2940-54. PubMed ID: 15970548
    [Abstract] [Full Text] [Related]

  • 34. Impaired osteoclast differentiation in subcutaneous implants of bone particles in osteopetrotic mutants.
    Glowacki J, Cox KA, Wilcon S.
    Bone Miner; 1989 Mar 01; 5(3):271-8. PubMed ID: 2655776
    [Abstract] [Full Text] [Related]

  • 35. Bone metabolism in the osteopetrotic rat mutation microphthalmia blanc.
    Cielinski MJ, Marks SC.
    Bone; 1995 May 01; 16(5):567-74. PubMed ID: 7654471
    [Abstract] [Full Text] [Related]

  • 36. Neonatal reductions in osteoclast number and function account for the transient nature of osteopetrosis in the rat mutation microphthalmia blanc (mib).
    Cielinski MJ, Marks SC.
    Bone; 1994 May 01; 15(6):707-15. PubMed ID: 7873301
    [Abstract] [Full Text] [Related]

  • 37. Localization of the mutation responsible for osteopetrosis in the op rat to a 1.5-cM genetic interval on rat chromosome 10: identification of positional candidate genes by radiation hybrid mapping.
    Dobbins DE, Joe B, Hashiramoto A, Salstrom JL, Dracheva S, Ge L, Wilder RL, Remmers EF.
    J Bone Miner Res; 2002 Oct 01; 17(10):1761-7. PubMed ID: 12369779
    [Abstract] [Full Text] [Related]

  • 38. Experimental studies of osteopetrosis in laboratory animals.
    Seifert MF, Popoff SN, Jackson ME, MacKay CA, Cielinski M, Marks SC.
    Clin Orthop Relat Res; 1993 Sep 01; (294):23-33. PubMed ID: 8358920
    [Abstract] [Full Text] [Related]

  • 39. Osteoclastic acid ATPase: biochemical and histochemical studies of the osteopetrotic mutations in the rat.
    Ek-Rylander B, Marks SC, Hammarström LE, Andersson GN.
    Bone Miner; 1989 Mar 01; 5(3):309-21. PubMed ID: 2524232
    [Abstract] [Full Text] [Related]

  • 40. Schlafen2 mutation in mice causes an osteopetrotic phenotype due to a decrease in the number of osteoclast progenitors.
    Omar I, Guterman-Ram G, Rahat D, Tabach Y, Berger M, Levaot N.
    Sci Rep; 2018 Aug 29; 8(1):13005. PubMed ID: 30158544
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.